Insights

Acquisition Synergy KCR has been acquired by ICON plc, creating a combined entity with enhanced resources, global reach, and integrated CRO capabilities. This signals opportunities for expanded service offerings, larger-scale programs, and cross-sell potential to ICON’s existing client base.

Biotech Focus KCR’s bespoke approach for emerging biotech clients represents a gateway to early-phase and growth-stage programs. Leverage ICON’s scale to position premium CRO services to biotech companies transitioning from discovery to development.

Full-Service Potential The integration with ICON broadens capabilities across the drug development lifecycle. Position end-to-end solutions from discovery support through development and outsourcing, appealing to sponsors seeking one integrated partner.

Tech Enablement KCR’s tech stack and data capabilities (SAS/GRAPH, SAP, ARISg, SAP R/3, analytics tools) can be highlighted to clients prioritizing data-driven studies, dashboards, and scalable project management within the ICON ecosystem.

Scale & Reach With ICON’s global footprint and KCR’s mid-size agility, target mid-to-large biopharma and CRO programs that require flexible capacity, rapid onboarding, and seamless collaboration across regions.

KCR Tech Stack

KCR uses 8 technology products and services including Canva, SAS/GRAPH, Microsoft Transact-SQL, and more. Explore KCR's tech stack below.

  • Canva
    Audio, Video, Graphics
  • SAS/GRAPH
    Business Intelligence
  • Microsoft Transact-SQL
    Database Management
  • Figma
    Design
  • SAP R/3
    Enterprise Resource Planning
  • ARISg
    Governance, Risk And Compliance
  • Active Directory Federation Services
    Identity And Access Management
  • SigmaPlot
    Visualisation Software

KCR's Email Address Formats

KCR uses at least 2 format(s):
KCR Email FormatsExamplePercentage
First.Last@kcrcro.comJohn.Doe@kcrcro.com
93%
Last@kcrcro.comDoe@kcrcro.com
4%
FirstLast@kcrcro.comJohnDoe@kcrcro.com
2%
Last.First@kcrcro.comDoe.John@kcrcro.com
1%
First.Last@iconplc.comJohn.Doe@iconplc.com
93%
FirstLast@iconplc.comJohnDoe@iconplc.com
4%
First.L@iconplc.comJohn.D@iconplc.com
2%
Last.First@iconplc.comDoe.John@iconplc.com
1%

Frequently Asked Questions

What is KCR's phone number?

Minus sign iconPlus sign icon
You can contact KCR's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is KCR's stock symbol?

Minus sign iconPlus sign icon
KCR is a publicly traded company; the company's stock symbol is RCGE.

What is KCR's official website and social media links?

Minus sign iconPlus sign icon
KCR's official website is iconplc.com and has social profiles on LinkedIn.

How much revenue does KCR generate?

Minus sign iconPlus sign icon
As of July 2026, KCR's annual revenue is estimated to be $1B - $10B.

What is KCR's NAICS code?

Minus sign iconPlus sign icon
KCR's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does KCR have currently?

Minus sign iconPlus sign icon
As of July 2026, KCR has approximately 500 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: D. D.Ceo: K. K.Chief Financial Officer: P. B.. Explore KCR's employee directory with LeadIQ.

What industry does KCR belong to?

Minus sign iconPlus sign icon
KCR operates in the Pharmaceutical Manufacturing industry.

What technology does KCR use?

Minus sign iconPlus sign icon
KCR's tech stack includes CanvaSAS/GRAPHMicrosoft Transact-SQLFigmaSAP R/3ARISgActive Directory Federation ServicesSigmaPlot.

What is KCR's email format?

Minus sign iconPlus sign icon
KCR's email format typically follows the pattern of First.Last@kcrcro.com. Find more KCR email formats with LeadIQ.

When was KCR founded?

Minus sign iconPlus sign icon
KCR was founded in 1997.
KCR logo

KCR

Pharmaceutical ManufacturingMasovian, Poland201-500 Employees

KCR operates as a contract research organization within pharmaceutical development, providing tailored services to emerging biotechnology companies. In August 2024, ICON plc completed its acquisition of KCR, bringing the Polish CRO into ICON’s global organization. The integration gives access to greater resources to support growth and development. The combined entity emphasizes collaborative culture and accountability, aiming to deliver innovative clinical development solutions for sponsors by leveraging KCR’s client-focused delivery with ICON’s scale. Based in Warsaw, in the Masovian region of Poland, the company sits within ICON’s worldwide network as a mid-sized CRO serving early-stage biotech clients.

Section iconCompany Overview

Phone number
Stock Symbol
RCGE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
201-500

Section iconFunding & Financials

  • $1B - $10B

    KCR's revenue is estimated to be in the range of $1B - $10B

Section iconFunding & Financials

  • $1B - $10B

    KCR's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.